Concepedia

Antibodies reactive with the protein core of MUC1 mucin are present in ovarian cancer patients and healthy women

Elizabeth R. Richards, Peter L. Devine, Rachel J. Quin, J D Fontenot, Bruce G. Ward, Michael A. McGuckin

Cancer Immunology Immunotherapy · 1998 · 67 citations · 25 references

DOIFull text

Open access

Concepts

References

25

Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components.

Jelle Wesseling, S W van der Valk, Hans L. Vos et al. · The Journal of Cell Biology · 1995 · 494 citations · Full text

, , +17

A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1.

Jelle Wesseling, S W van der Valk, John Hilkens · Molecular Biology of the Cell · 1996 · 384 citations

, , +17

Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.

Y Kotera, J D Fontenot, Gabriele Pecher et al. · PubMed · 1994 · 314 citations

, , +15

A Phase I Trial of a Synthetic Mucin Peptide Vaccine

James S. Goydos, Elaine M. Elder, Theresa L. Whiteside et al. · Journal of Surgical Research · 1996 · 272 citations

, , +12

Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction.

E. van de Wiel-van Kemenade, M J Ligtenberg, Annemiek J. de Boer et al. · The Journal of Immunology · 1993 · 222 citations · Full text

, , +14